Cite
HARVARD Citation
Abe, K. et al. (2014). Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotrophic lateral sclerosis and frontotemporal degeneration. 15 (7), pp. 610-617. [Online].